Shopping Cart 0
Cart Subtotal
USD 0

Luminex Corp (LMNX)-Product Pipeline Analysis, 2017 Update

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 750

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 1500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 2250
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Luminex Corp (Luminex) is a medical devices company that carries out the development, manufacturing and marketing of proprietary biological testing technologies. The company offers wide range of products that include instruments, assays, reagents and accessories, software and replacement parts. Its proprietary technologies consist of xMAP technology, xTAG and MultiCode technology. Luminex offers its products to various markets such as clinical diagnostics; pharmaceutical drug discovery; biomedical research including personalized medicine, genomic and proteomic research, biodefense research and food safety. It also provides support and training services for its products. The company has operations in North America, Europe and Asia-Pacific th. Luminex is headquartered in Texas, the US.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

The report analyzes all pipeline products in development for the company Luminex Corp

The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

The report provides detailed description of products in development, technical specification and functions

The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

To formulate effective Research & Development strategies

Develop market-entry and market expansion strategies

Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Luminex Corp Company Overview 6

Luminex Corp Company Snapshot 6

Luminex Corp Pipeline Products and Ongoing Clinical Trials Overview 6

Luminex Corp-Pipeline Analysis Overview 9

Business Description 9

Luminex Corp-Key Facts 9

Luminex Corp-Major Products and Services 10

Luminex Corp Pipeline Products by Development Stage 12

Luminex Corp Ongoing Clinical Trials by Trial Status 15

Luminex Corp Pipeline Products Overview 17

ARIES-Bordetella Assay 17

ARIES-Bordetella Assay Product Overview 17

ARIES-Bordetella Assay Clinical Trial 18

ARIES-C. Difficile Assay 19

ARIES-C. Difficile Assay Product Overview 19

ARIES-C. Difficile Assay Clinical Trial 20

ARIES-MRSA Assay 21

ARIES-MRSA Assay Product Overview 21

ARIES-Norovirus Assay 22

ARIES-Norovirus Assay Product Overview 22

ARIES-Norovirus Assay Clinical Trial 23

ARIES-Tuberculosis Assay 24

ARIES-Tuberculosis Assay Product Overview 24

Aries LDT Catridge 25

Aries LDT Catridge Product Overview 25

ARIES V2 26

ARIES V2 Product Overview 26

ATLAS System-Enteric Assay 27

ATLAS System-Enteric Assay Product Overview 27

Companion Diagnostic Device-Alzheimer's Disease 28

Companion Diagnostic Device-Alzheimer's Disease Product Overview 28

Diagnostic Assay-MRSA 29

Diagnostic Assay-MRSA Product Overview 29

Diagnostic Assay-RVP II 30

Diagnostic Assay-RVP II Product Overview 30

Fungal Panel Assay 31

Fungal Panel Assay Product Overview 31

Meningitis Panel Assay 32

Meningitis Panel Assay Product Overview 32

Next Generation Fully Automated Instrument 33

Next Generation Fully Automated Instrument Product Overview 33

Next Generation Respiratory Viral Panel 34

Next Generation Respiratory Viral Panel Product Overview 34

Next Generation Verigene Flex System 35

Next Generation Verigene Flex System Product Overview 35

Portable Field Deployed Diagnostic Tool 36

Portable Field Deployed Diagnostic Tool Product Overview 36

Ultra-Sensitive Assay- Creutzfeldt-Jakob Disease 37

Ultra-Sensitive Assay- Creutzfeldt-Jakob Disease Product Overview 37

Ultra-Sensitive Assay-Alzheimer's Disease 38

Ultra-Sensitive Assay-Alzheimer's Disease Product Overview 38

Ultra-Sensitive Protein Assay-Autoimmune Disease 39

Ultra-Sensitive Protein Assay-Autoimmune Disease Product Overview 39

Ultra-Sensitive Protein Assay-Cardiac Troponin I 40

Ultra-Sensitive Protein Assay-Cardiac Troponin I Product Overview 40

Ultra-Sensitive Protein Assay-Chronic Heart Failure 41

Ultra-Sensitive Protein Assay-Chronic Heart Failure Product Overview 41

Ultra-Sensitive Protein Assay-Respiratory Disease 42

Ultra-Sensitive Protein Assay-Respiratory Disease Product Overview 42

Ultra-Sensitive Protein Assay-Sepsis 43

Ultra-Sensitive Protein Assay-Sepsis Product Overview 43

Verigene-Hemochromatosis (HFE) Nucleic Acid Test 44

Verigene-Hemochromatosis (HFE) Nucleic Acid Test Product Overview 44

Verigene Blood Culture-Fungal Test (BC-F) 45

Verigene Blood Culture-Fungal Test (BC-F) Product Overview 45

Verigene Processor SP-Multiplex Blood Culture ID Test 46

Verigene Processor SP-Multiplex Blood Culture ID Test Product Overview 46

Verigene Processor SP System-Hemochromatosis (HFE) Nucleic Acid Test 47

Verigene Processor SP System-Hemochromatosis (HFE) Nucleic Acid Test Product Overview 47

Verigene Yeast Blood Culture Test (BC-Y) 48

Verigene Yeast Blood Culture Test (BC-Y) Product Overview 48

Luminex Corp-Key Competitors 49

Luminex Corp-Key Employees 50

Luminex Corp-Key Employee Biographies 51

Luminex Corp-Locations And Subsidiaries 52

Head Office 52

Other Locations & Subsidiaries 52

Recent Developments 54

Luminex Corp, Recent Developments 54

Feb 06, 2017: Luminex Reports Fourth Quarter And Full Year 2016 Results 54

Jan 09, 2017: Luminex Announces Preliminary Revenue for Fourth Quarter 2016 and Issues 2017 Revenue Guidance 54

Jan 04, 2017: Luminex Receives FDA Clearance for ARIES GBS Assay 55

Nov 17, 2016: ARIES System and Flu A/B & RSV Assay Evaluated by Erasmus MC in New Publication 55

Oct 31, 2016: Luminex Reports Third Quarter 2016 Results; Raises Full Year Guidance 56

Sep 30, 2016: xTAG Gastrointestinal Pathogen Panel (GPP) Now Available Through Accu Reference Medical Lab 56

Aug 03, 2016: Luminex Receives FDA Clearance for New Molecular Test for Identification and Differentiation of Influenza A/B and Respiratory Syncytial Virus 57

Jul 28, 2016: Luminex Reports Second Quarter 2016 Results 58

Jul 06, 2016: Luminex Receives FDA Clearance and CE-IVD Mark for the ARIES M1 System 58

Jun 01, 2016: Luminex Receives CE-IVD Mark for ARIES Flu A/B & RSV Assay 58

Appendix 60

Methodology 60

About GlobalData 62

Contact Us 62

Disclaimer 62


List Of Figure

List of Figures

Luminex Corp Pipeline Products by Equipment Type 7

Luminex Corp Pipeline Products by Development Stage 12

Luminex Corp Ongoing Clinical Trials by Trial Status 15


List Of Table

List of Tables

Luminex Corp Pipeline Products and Ongoing Clinical Trials Overview 6

Luminex Corp Pipeline Products by Equipment Type 7

Luminex Corp Pipeline Products by Indication 8

Luminex Corp Ongoing Clinical Trials by Trial Status 8

Luminex Corp, Key Facts 9

Luminex Corp, Major Products and Services 10

Luminex Corp Number of Pipeline Products by Development Stage 12

Luminex Corp Pipeline Products Summary by Development Stage 13

Luminex Corp Ongoing Clinical Trials by Trial Status 15

Luminex Corp Ongoing Clinical Trials Summary 16

ARIES-Bordetella Assay-Product Status 17

ARIES-Bordetella Assay-Product Description 17

ARIES-Bordetella Assay-A Multi-site Clinical Evaluation of the ARIES Bordetella Assay in Symptomatic Patients 18

ARIES-C. Difficile Assay-Product Status 19

ARIES-C. Difficile Assay-Product Description 19

ARIES-C. Difficile Assay-A Multi-site Clinical Evaluation of the ARIES Clostridium Difficile Assay in Symptomatic Patients 20

ARIES-MRSA Assay-Product Status 21

ARIES-MRSA Assay-Product Description 21

ARIES-Norovirus Assay-Product Status 22

ARIES-Norovirus Assay-Product Description 22

ARIES-Norovirus Assay-A Multi-site Clinical Evaluation of the ARIES Norovirus Assay in Patients with Signs and Symptoms of Acute Gastroenteritis 23

ARIES-Tuberculosis Assay-Product Status 24

ARIES-Tuberculosis Assay-Product Description 24

Aries LDT Catridge-Product Status 25

Aries LDT Catridge-Product Description 25

ARIES V2-Product Status 26

ARIES V2-Product Description 26

ATLAS System-Enteric Assay-Product Status 27

ATLAS System-Enteric Assay-Product Description 27

Companion Diagnostic Device-Alzheimer's Disease-Product Status 28

Companion Diagnostic Device-Alzheimer's Disease-Product Description 28

Diagnostic Assay-MRSA-Product Status 29

Diagnostic Assay-MRSA-Product Description 29

Diagnostic Assay-RVP II-Product Status 30

Diagnostic Assay-RVP II-Product Description 30

Fungal Panel Assay-Product Status 31

Fungal Panel Assay-Product Description 31

Meningitis Panel Assay-Product Status 32

Meningitis Panel Assay-Product Description 32

Next Generation Fully Automated Instrument-Product Status 33

Next Generation Fully Automated Instrument-Product Description 33

Next Generation Respiratory Viral Panel-Product Status 34

Next Generation Respiratory Viral Panel-Product Description 34

Next Generation Verigene Flex System-Product Status 35

Next Generation Verigene Flex System-Product Description 35

Portable Field Deployed Diagnostic Tool-Product Status 36

Portable Field Deployed Diagnostic Tool-Product Description 36

Ultra-Sensitive Assay- Creutzfeldt-Jakob Disease-Product Status 37

Ultra-Sensitive Assay- Creutzfeldt-Jakob Disease-Product Description 37

Ultra-Sensitive Assay-Alzheimer's Disease-Product Status 38

Ultra-Sensitive Assay-Alzheimer's Disease-Product Description 38

Ultra-Sensitive Protein Assay-Autoimmune Disease-Product Status 39

Ultra-Sensitive Protein Assay-Autoimmune Disease-Product Description 39

Ultra-Sensitive Protein Assay-Cardiac Troponin I-Product Status 40

Ultra-Sensitive Protein Assay-Cardiac Troponin I-Product Description 40

Ultra-Sensitive Protein Assay-Chronic Heart Failure-Product Status 41

Ultra-Sensitive Protein Assay-Chronic Heart Failure-Product Description 41

Ultra-Sensitive Protein Assay-Respiratory Disease-Product Status 42

Ultra-Sensitive Protein Assay-Respiratory Disease-Product Description 42

Ultra-Sensitive Protein Assay-Sepsis-Product Status 43

Ultra-Sensitive Protein Assay-Sepsis-Product Description 43

Verigene-Hemochromatosis (HFE) Nucleic Acid Test-Product Status 44

Verigene-Hemochromatosis (HFE) Nucleic Acid Test-Product Description 44

Verigene Blood Culture-Fungal Test (BC-F)-Product Status 45

Verigene Blood Culture-Fungal Test (BC-F)-Product Description 45

Verigene Processor SP-Multiplex Blood Culture ID Test-Product Status 46

Verigene Processor SP-Multiplex Blood Culture ID Test-Product Description 46

Verigene Processor SP System-Hemochromatosis (HFE) Nucleic Acid Test-Product Status 47

Verigene Processor SP System-Hemochromatosis (HFE) Nucleic Acid Test-Product Description 47

Verigene Yeast Blood Culture Test (BC-Y)-Product Status 48

Verigene Yeast Blood Culture Test (BC-Y)-Product Description 48

Luminex Corp, Key Employees 50

Luminex Corp, Key Employee Biographies 51

Luminex Corp, Other Locations 52

Luminex Corp, Subsidiaries 52

Glossary 61

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Luminex Corp, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies